Related references
Note: Only part of the references are listed.PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer
Orla T. Cox et al.
CANCER RESEARCH (2019)
Targeting Macrophages in Cancer: From Bench to Bedside
Ashleigh R. Poh et al.
FRONTIERS IN ONCOLOGY (2018)
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+Breast Cancer
Matthew P. Humphries et al.
JOURNAL OF ONCOLOGY (2018)
Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer
Jaya Gautam et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients
Victoria Sopik et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival
Ines Vasconcelos et al.
BREAST (2016)
A bioavailable cathepsin S nitrile inhibitor abrogates tumor development
Richard D. A. Wilkinson et al.
MOLECULAR CANCER (2016)
Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer
Wan-Li Liu et al.
ONCOTARGET (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Cathepsin S: therapeutic, diagnostic, and prognostic potential
Richard D. A. Wilkinson et al.
BIOLOGICAL CHEMISTRY (2015)
A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression
S. J. Salpeter et al.
ONCOGENE (2015)
Biomarkers in triple negative breast cancer: A review
Budhi S. Yadav et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2015)
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response
Pascal Jezequel et al.
BREAST CANCER RESEARCH (2015)
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer
David P. Boyle et al.
HISTOPATHOLOGY (2014)
Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization
Min Yang et al.
MOLECULAR CANCER (2014)
Analysis of tumour-and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S
Lisa Sevenich et al.
NATURE CELL BIOLOGY (2014)
Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization
Donna M. Small et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
A Nonpeptidic Cathepsin S Activity-Based Probe for Noninvasive Optical Imaging of Tumor-Associated Macrophages
Martijn Verdoes et al.
CHEMISTRY & BIOLOGY (2012)
Hazard of Breast Cancer-Specific Mortality among Women with Estrogen Receptor-Positive Breast Cancer after Five Years from Diagnosis: Implication for Extended Endocrine Therapy
Ke-Da Yu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study
J. A. Gormley et al.
BRITISH JOURNAL OF CANCER (2011)
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Tanaya Shree et al.
GENES & DEVELOPMENT (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
The Emerging Relevance of the Cysteine Protease Cathepsin S in Disease
Donna M. Small et al.
CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM (2011)
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
Vasilena Gocheva et al.
GENES & DEVELOPMENT (2010)
Cathepsin S Mediates Gastric Cancer Cell Migration and Invasion via a Putative Network of Metastasis-Associated Proteins
Yang Yixuan et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis
Roberta E. Burden et al.
CLINICAL CANCER RESEARCH (2009)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Cathepsin S expression: An independent prognostic factor in glioblastoma tumours - A pilot study
Thomas Flannery et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis
V Gocheva et al.
GENES & DEVELOPMENT (2006)
Age-related variations in the use of axillary dissection: A survival analysis of 8038 women with T1-ST2 breast cancer
PT Truong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Share Paper
